Is There Such A Thing As A Benign Lymphoma?

Usually, even if a subtype of lymphoma is known to be indolent (slow-growing), it is considered a malignant disease, one that, if left untreated and unchecked, would eventually prove to be fatal.

However, there is such a thing as a benign lymphoma, referred to clinically as either a pseudolymphoma or as a benign lymphoid hyperplasia (BLH).

Benign lymphoma tends to mimic malignant lymphomas both in how they act (clinically) and in how they appear under the microscope (histologically). Such lymphomas have been reported in various sites across the body, including the skin, the lungs, the liver, the orbits, the gastrointestinal tract, and in soft tissue sites. Unfortunately in many cases, these lymphomas so accurately mimic malignant lymphomas that proper diagnosis can be very difficult.

Despite their 'benign' status, these lymphomas often demand some sort of treatment, in part for fear that they develop into malignant lymphomas. They may also be treated to relieve lymphoma symptoms of excessive nodal swelling.

Sources:

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap